The absence of such events in PMBL may suggest either that BCR and/or TLR stimulation do not play a tumour-promoting role in this disease, or that mutations in inhibitory NF-κB factors are sufficient to induce a stronger NF-κB response to stimuli from the tumour microenvironment and/or to soluble factors. Here, BCR is linked to neoplasm.